Clozapine prescribing in COVID-19 positive medical inpatients: a case series

There is both uncertainty regarding the safety of clozapine in COVID-19 patients owing to limited published data and a lack of consensus on continuing clozapine in patients with severe respiratory infections. COVID-19 is known to induce an acute immune response which can affect haematological parame...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, Matthew, Bano, Felicity, Calcia, Marilia, McMullen, Isabel, Sin Fai Lam, Chun Chiang, Smith, Laura Jane, Taylor, David, Gee, Siobhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493264/
https://www.ncbi.nlm.nih.gov/pubmed/32974002
http://dx.doi.org/10.1177/2045125320959560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493264/
https://www.ncbi.nlm.nih.gov/pubmed/32974002
http://dx.doi.org/10.1177/2045125320959560

Ejemplares similares